a16z Podcast | How to Live Longer and Better

Market Context & Drivers

• The longevity sector is entering a phase of tractability driven by the "explosion of technology" capable of measuring biology as an information science.
• Increased computing power and data volume are allowing complex biological processes to be modeled rather than just observed.
• Three exploding areas in the field include: addressing the root causes of aging, harnessing the body's natural defenses, and improving predictive healthcare.
• Experts project these combined approaches could increase human healthspan and lifespan by 5 to 15 years within current lifetimes.

Precision Medicine & Data Integration

• Precision health aims to move from reactive, "Byzantine" medicine to proactive prevention based on individual baselines.
• The field is transitioning from "precision medicine" to "precision health," utilizing longitudinal data to predict disease trajectories before symptoms appear.
• Current capabilities include catching early-stage heart issues, pre-cancer, and early lymphoma through close monitoring of 100-person study groups.
• Success in early detection relies on establishing personal baselines; for example, one speaker identified Lyme disease via deviations in smartwatch heart rate and blood oxygen data.

Biomarkers & Biological Age

• A functional biomarker must predict future mortality or morbidity (e.g., risk of heart disease or Alzheimer's in 10 years).
• BioAge identifies molecular signatures using the proteome and metabolome from biobank samples with decades of historical health records.
• Personal experimentation showed a bio-age algorithm drop from 57.4 to 31.4 following intervention with Metformin and NAD boosters.
• The "analog" system of the epigenome is identified as a key frontier for reversing aging, distinct from the "digital" DNA code.
• Senescent cells ("zombie cells") are a primary target; removing them has successfully rejuvenated mice.

Societal & Economic Impact

• 75% of current annual healthcare costs are attributed to chronic diseases in the elderly.
• Compressing morbidity (keeping people healthy until sudden death, similar to supercentenarians) is projected to yield massive economic returns.
• Reducing major diseases like cancer by 10% could save the U.S. approximately $3–4 trillion in the long run.
• Increased productivity from extended healthy lifespans offers a better ROI for society compared to current retirement models.

Data Ownership & Privacy

• A "tug of war" exists between current providers who claim data ownership and the prevailing view that individuals should own their own health data.
• Experts advocate for individuals to aggregate and track their own data to create a "time capsule" of information for future medical use.
• Future healthcare will likely involve continuous monitoring, moving from an average of 0 sensors on a person to a model similar to cars, which have 400 sensors.

Actionable Interventions & Challenges

• Lifestyle Factors: Exercise and diet remain robustly linked to all-cause mortality, though the goal is to mimic these benefits via pharmacology.
• Pharmacological Targets: Research focuses on mimicking calorie restriction and lean body states using pathways like sirtuins, mTOR, and AMP kinase.
• Clinical Barriers: A major limiting step is the clinical trial requirement to isolate single variables for pathology prediction, whereas future models will use millions of inputs (similar to search engine algorithms).
• Immediate Recommendations: Experts suggest tracking pulse and activity, considering Metformin (with caution), and maintaining a continuous data log regardless of current symptomatic status.